These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 38653946)
21. MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Xia P; Zhang H; Xu K; Jiang X; Gao M; Wang G; Liu Y; Yao Y; Chen X; Ma W; Zhang Z; Yuan Y Cell Death Dis; 2021 Jul; 12(7):691. PubMed ID: 34244479 [TBL] [Abstract][Full Text] [Related]
22. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway. Song W; Zhang J; Xia Q; Sun M Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201 [No Abstract] [Full Text] [Related]
23. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234 [TBL] [Abstract][Full Text] [Related]
24. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy. Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107 [TBL] [Abstract][Full Text] [Related]
25. Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma. Dong FL; Xu ZZ; Wang YQ; Li T; Wang X; Li J J Nanobiotechnology; 2024 May; 22(1):298. PubMed ID: 38811968 [TBL] [Abstract][Full Text] [Related]
26. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1. Dong ZB; Wu HM; He YC; Huang ZT; Weng YH; Li H; Liang C; Yu WM; Chen W Cell Death Dis; 2022 Jan; 13(1):35. PubMed ID: 35013144 [TBL] [Abstract][Full Text] [Related]
27. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis. Fu D; Ji Q; Wang C; Yu L; Yu R Cell Cycle; 2021 Dec; 20(23):2476-2493. PubMed ID: 34720052 [TBL] [Abstract][Full Text] [Related]
28. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1. Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766 [TBL] [Abstract][Full Text] [Related]
29. Long Noncoding RNA Gong X; Zhu Z Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535 [No Abstract] [Full Text] [Related]
30. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma. Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485 [TBL] [Abstract][Full Text] [Related]
32. The Significance of Circular RNA DDX17 in Prostate Cancer. Lin Q; Cai J; Wang QQ Biomed Res Int; 2020; 2020():1878431. PubMed ID: 32904557 [TBL] [Abstract][Full Text] [Related]
33. Exosomal circEPB41L2 serves as a sponge for miR-21-5p and miR-942-5p to suppress colorectal cancer progression by regulating the PTEN/AKT signalling pathway. Jiang Z; Hou Z; Li L; Liu W; Yu Z; Chen S Eur J Clin Invest; 2021 Sep; 51(9):e13581. PubMed ID: 34022068 [TBL] [Abstract][Full Text] [Related]
34. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006 [TBL] [Abstract][Full Text] [Related]
35. Silencing Zhu Q; Ren H; Li X; Qian B; Fan S; Hu F; Xu L; Zhai B Aging (Albany NY); 2020 Nov; 12(22):22975-23003. PubMed ID: 33203790 [TBL] [Abstract][Full Text] [Related]
36. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway. Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132 [TBL] [Abstract][Full Text] [Related]
37. Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis. Zhang D; Zhang Y; Zhang X; Zhai H; Sun X; Li Y Dig Dis Sci; 2022 Feb; 67(2):585-597. PubMed ID: 33559088 [TBL] [Abstract][Full Text] [Related]
38. LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells. Sun J; Zheng X; Wang B; Cai Y; Zheng L; Hu L; Lu X; Xie S; Zhang X; Liu H; Ye L Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):261-270. PubMed ID: 35130616 [TBL] [Abstract][Full Text] [Related]
39. EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis. Liu X; Gao X; Yang Y; Yang D; Guo Q; Li L; Liu S; Cong W; Lu S; Hou L; Wang B; Li N Apoptosis; 2024 Aug; 29(7-8):1161-1184. PubMed ID: 38743191 [TBL] [Abstract][Full Text] [Related]
40. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. Zhang Z; Tan X; Luo J; Yao H; Si Z; Tong JS Cell Death Dis; 2020 Oct; 11(10):902. PubMed ID: 33097691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]